Analyzing Subvisible Particles in Protein Drug Products: a Comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM)

How Subvisible Particles Become Invisible—Relevance of the Refractive Index for Protein Particle Analysis

(2013) Sarah Zölls et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Micro–Flow Imaging and Resonant Mass Measurement (Archimedes) – Complementary Methods to Quantitatively Differentiate Protein Particles and Silicone Oil Droplets

(2013) Daniel Weinbuch et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Protein Particulate Detection Issues in Biotherapeutics Development—Current Status

(2012) Tapan K. Das   AAPS PHARMSCITECH

Rationalizing Nanomaterial Sizes Measured by Atomic Force Microscopy, Flow Field-Flow Fractionation, and Dynamic Light Scattering: Sample Preparation, Polydispersity, and Particle Structure

(2012) M. Baalousha et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity

(2012) James G. Barnard et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Possibilities and limitations of different analytical methods for the size determination of a bimodal dispersion of metallic nanoparticles

(2011) Dirk Mahl et al.   COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS

Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation

(2010) John Carpenter et al.   BIOLOGICALS

Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates

(2010) Vasco Filipe et al.   PHARMACEUTICAL RESEARCH

Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development

(2010) John den Engelsman et al.   PHARMACEUTICAL RESEARCH

Protein aggregation: Pathways, induction factors and analysis

(2008) Hanns-Christian Mahler et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality

(2008) John F. Carpenter et al.   JOURNAL OF PHARMACEUTICAL SCIENCES